Havemeyer Place »

Halozyme Therapeutics shares owned by Havemeyer Place

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Havemeyer Place from 13F filings

Historical chart of Havemeyer Place investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Havemeyer Place consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Havemeyer Place

Quarter filed Position value Share count Share price at filing
2026-03-31 $852k 13k 64.63

More positions owned by Havemeyer Place

Arm Holdings Sponsored Ads (ARM)
Cummins (CMI)
Autodesk (ADSK)
NVIDIA Corporation (NVDA)
Blackstone Group Inc Com Cl A (BX)
Johnson & Johnson (JNJ)
Dow (DOW)
Trane Technologies SHS (TT)
Advanced Micro Devices (AMD)
Capital One Financial (COF)
Veeva Sys Cl A Com (VEEV)
TTM Technologies (TTMI)
Te Connectivity Ord Shs (TEL)
Anthem (ELV)
Draftkings Com Cl A (DKNG)

View all positions for Havemeyer Place

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Invesco
Bank of America Corporation
Robeco Investment Management
Morgan Stanley
William Blair Investment Management
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
Alliancebernstein

View all funds holding Halozyme Therapeutics